Dr. James Somauroo, Contributor

Author's posts

Decoding The Science Behind The 2019 Nobel Prize For Medicine

Three researchers have been awarded the Nobel Prize for Medicine for discovering the complex processes behind how human cells respond to oxygen. William Kaelin Jr, Sir Peter Ratcliffe and Gregg Semenza’s pioneering work is now paving the way for innova…

New Microsoft Report Claims U.K. Is Behind The Rest Of The World On AI

A new report, unveiled October 1 by Microsoft UK, claims that British organizations risk being overtaken by their global counterparts unless the use of artificial intelligence (AI) technology is accelerated.

Butterfly, A $1.25 Billion Heathtech Company, Launches New Ultrasound Technology In The U.K.

Wednesday September 25 saw the U.K. launch of a device that has the potential to change the way ultrasound scans are performed.

Malaria Vaccine 30 Years And $1 Billion In The Making Now Deployed In Third Country

After more than thirty years in development and almost $1 billion of investment, a malaria vaccine is now being deployed in three African countries: Malawi, Ghana and, as of last week, Kenya, where it is now a routine part of children’s routine immuniz…

InsightRX Raises $10 Million To Personalize Drug Doses

The funding round was led by HealthX Ventures with participation from Rock Health, OSF Healthcare, Leawood Venture Capital, Premier Inc. and previous investor GreatPoint Ventures.

Healthy.io Raises $60M Series C And Receives FDA Clearance For Smartphone-Based Diagnostic Test

Today, Healthy.io, an Israel-based healthtech startup that turns smartphone cameras into urine-testing medical devices, has announced a $60 million Series C funding round and FDA clearance.

Fitbit Partners With Singapore Government To Offer Trackers To 5.6 Million People

This week, Fitbit (NYSE: FIT) announced that it will be collaborating with Singapore’s government to provide their 5.6 million population with fitness trackers in a nationwide public health initiative.

Thriva Secures $7.3M Series A For Proactive Healthcare

This week, Thriva, a proactive health company, has announced a £6 million ($7.3 million) Series A funding round as it builds towards its ambitious vision: to put optimal health in anyone’s hands.

Could The NHS Really Sell Its Data For $12 Billion?

A new report by consulting firm EY suggests that if the U.K. National Health Service (NHS) datasets were put to use, their value could be up to £9.6 billion ($12 billion) per year. But how realistic is this valuation?

Telemedicine Service Zava Raises $32M Series A To Scale Across Europe

This week, Zava, a telemedicine provider with over 3 million paid consultations to date, has announced a $32 million Series A investment ahead of its launch into statutory healthcare systems in Germany, France and the UK.